Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis B virus infection--natural history and clinical consequences.

× No keyword cloud information.

695 in total

1. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.

Authors: N Gara; X Zhao; M T Collins; W H Chong; D E Kleiner; T Jake Liang; M G Ghany; J H Hoofnagle
Journal: Aliment Pharmacol Ther Date: 2012-04-16 Impact factor: 8.171

2. Humanized murine model for HBV and HCV using human induced pluripotent stem cells.

Authors: Xiao-Ling Zhou; Gareth J Sullivan; Pingnan Sun; In-Hyun Park
Journal: Arch Pharm Res Date: 2012-02-28 Impact factor: 4.946

Review 3. Microvesicles and viral infection.

Authors: David G Meckes; Nancy Raab-Traub
Journal: J Virol Date: 2011-10-05 Impact factor: 5.103

4. Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians.

Authors: Harry Wu; Colina Yim; Alex Chan; Michael Ho; Jenny Heathcote
Journal: Can J Gastroenterol Date: 2009-01 Impact factor: 3.522

5. HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Authors: T-W Wu; C-C Chu; H-W Chang Liao; S-K Lin; T-Y Ho; M Lin; H H Lin; L-Y Wang
Journal: Genes Immun Date: 2013-11-28 Impact factor: 2.676

6. Origin and biology of simian immunodeficiency virus in wild-living western gorillas.

Authors: Jun Takehisa; Matthias H Kraus; Ahidjo Ayouba; Elizabeth Bailes; Fran Van Heuverswyn; Julie M Decker; Yingying Li; Rebecca S Rudicell; Gerald H Learn; Cecile Neel; Eitel Mpoudi Ngole; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal: J Virol Date: 2008-12-10 Impact factor: 5.103

Hepatitis B virus infection--natural history and clinical consequences.

1. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.

2. Humanized murine model for HBV and HCV using human induced pluripotent stem cells.

Review 3. Microvesicles and viral infection.

4. Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians.

5. HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

6. Origin and biology of simian immunodeficiency virus in wild-living western gorillas.

7. HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study.

Review 8. Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review.

9. Synthesis and anti-hepatitis B virus and anti-hepatitis C virus activities of 7-deazaneplanocin A analogues in vitro.

10. Type and cause of liver disease in Korea: single-center experience, 2005-2010.